Fig. 4From: Technical advance in targeted NGS analysis enables identification of lung cancer risk-associated low frequency TP53, PIK3CA, and BRAF mutations in airway epithelial cellsInter-cohort comparison of subject-specific mutation prevalence. Inter-cohort comparison of subject-specific mutation prevalence (mutations/target base/subject) in (a) TP53 exons only or (b) TP53 exons, PIK3CA, and BRAFBack to article page